Vir Biotechnology, Inc. (VIR)
NASDAQ·Healthcare·Biotechnology
$11.06
-3.74%
Mkt Cap $1.94B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (19 analysts)
$21.71
Range $18.00 – $30.00
Implied Upside
+96.4%
Consensus $21.71 vs current $11.06
NASDAQ·Healthcare·Biotechnology
$11.06
-3.74%
Mkt Cap $1.94B
Buy
2
Hold
0
Sell
0
Price Target (19 analysts)
$21.71
Range $18.00 – $30.00
+96.4%
Consensus $21.71 vs current $11.06